Categoria: Newsletter (Italian)
-
Inflation in France Drops to 0.9% in October
In today’s digest, French inflation drops to 0.9% with energy prices plunging 7%. The Fed cuts rates to 3.75%-4.00%, amid resilient U.S. corporate earnings.
-
Verification Lacking for News from Three Trusted Sources
Morning Intelligence – The Gist Morning Intelligence • Friday, October 31, 2025 the Gist View Mi dispiace, ma al momento non riesco a reperire – da tre…
-
Trade Truce: Trump and Xi Reach One-Year Agreement in Busan
In this evening’s analysis, Trump and Xi agree to a one-year trade truce, Meta plans a $25 billion bond sale, and the U.S. supports South Korea in nuclear…
-
D66 Gains 26-27 Seats in Dutch Election Night
In today’s news: the Dutch election sees D66 surge to 26-27 seats while PVV falls to 25. Quantum technology advances, and UK MPs express concerns over IP theft.
-
El-Fasher Fall Enables RSF to Commit Atrocities in Darfur
In today’s Evening Analysis, Sudan’s Darfur crisis escalates with RSF’s brutal actions amid a humanitarian disaster. Meanwhile, Nvidia becomes the first $5…
-
Pechino guida la raffinazione delle terre rare a Bruxelles
In today’s digest, the EU addresses China’s new export licenses on rare earths amid rising tensions with the U.S. over tariffs and tech. Meanwhile, the…
-
ASEAN-China Free Trade Area 3.0 Opens Huge Market
In this evening’s analysis, key stories include the signing of the ASEAN-China Free Trade Area 3.0, Japan’s diplomatic overtures to the U.S., and Israel’s…
-
EU Signs UN Cybercrime Convention in Hanoi Amid Criticism
EU signs a landmark UN cybercrime convention in Hanoi, joining 70 nations, amid concerns over digital rights and state surveillance. Meanwhile, the US…
-
USA-China Tariff Truce Boosts Markets, Offers Relief
In today’s Evening Analysis, markets rally on a fragile U.S.-China trade truce, with the Nikkei surpassing 50,000. Argentina sees financial gains…
-
Novartis Acquires Avidity Biosciences for $12 Billion
In today’s digest, Novartis announces a $12 billion acquisition of Avidity Biosciences to enhance its RNA therapy pipeline. Meanwhile, US debt is projected…
